Hoag Memorial Hospital Presbyterian
hoag.orgTotal trials
31
Active
5
Phase 3
0
Total enrollment
12,486
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| DZ-002 - 5 mg/kg, 6 mg/kg, or 7 mg/kg | — | — | — | — | — | 1 | |
| DCFPyL PET/CT | — | — | — | — | — | 1 | |
| Copper 61-PSMA PET/CT | — | — | — | — | — | 1 |
Next readouts
- 2022-07-15
- 2025-03-31
- 2028-11
Top conditions
- Lymphoma5
- Pancreatic Cancer3
- Melanoma (Skin)3
- Unspecified Adult Solid Tumor, Protocol Specific3
- Leukemia3
- Breast Cancer3
- Prostate Cancer2
- Kidney Cancer2
Frequently asked questions about Hoag Memorial Hospital Presbyterian
- How many clinical trials does Hoag Memorial Hospital Presbyterian have on ClinicalTrials.gov?
- Hoag Memorial Hospital Presbyterian is listed as the lead sponsor on 31 clinical trials in ClinicalTrials.gov, 5 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hoag Memorial Hospital Presbyterian's trials are in Phase 3?
- 0 of Hoag Memorial Hospital Presbyterian's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Hoag Memorial Hospital Presbyterian focus on?
- Hoag Memorial Hospital Presbyterian's most-studied conditions on ClinicalTrials.gov are Lymphoma, Pancreatic Cancer, Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific, Leukemia.
- When are Hoag Memorial Hospital Presbyterian's next clinical trial readouts?
- Hoag Memorial Hospital Presbyterian has 3 upcoming primary-completion readouts tracked here; the soonest is “PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer”, expected around 2022-07-15.